ACXP Acurx Pharmaceuticals Earnings per share increase in current year

Official company branding of acurxpharma.com (ACXP)

The annual net income per share history on the current GURU.Markets platform chart shows that 66.10 represents the latest metric reading. Acurx Pharmaceuticals (ACXP) is implementing eco-friendly waste disposal methods in compliance with ESG standards. The brand is valued for its innovative antibiotics targeting resistant microbes. Experienced management is effectively optimizing clinical trial strategies to minimize potential risks.

Earnings growth in current year: Acurx Pharmaceuticals Inc. (ACXP) for 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company Acurx Pharmaceuticals (ACXP)

- price and consensus price forecast:
Stock Quotes Acurx|ACXP - Price Target Chart
- market capitalization data:
Market Value Acurx Pharmaceuticals, Inc.|ACXP - Total Company Value
- business book valuation details:
Net Asset Value per Share Acurx Pharmaceuticals|ACXP - Book Capitalization|Market Value to Book Value Ratio acurxpharma.com|ACXP - Company Total Assets
- debt and liquidity details:
Debt to Capital Acurx Pharmaceuticals|ACXP - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Acurx Pharmaceuticals Inc.|ACXP - Company Aggregate Debts|Debts to Book Capitalization Acurx Pharmaceuticals|ACXP - Company Long-Term Debts|Company Current Liabilities Acurx Pharmaceuticals|Quick Ratio acurxpharma.com
- company profitability and valuation multiples indicators:
ACXP - Company Net Income|Expected Net Income Acurx Pharmaceuticals|ACXP - Price to Earnings Ratio|Price to Future Earnings Ratio Acurx Pharmaceuticals|ACXP - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Acurx Pharmaceuticals, Inc.|ACXP - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Acurx Pharmaceuticals|ACXP - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months acurxpharma.com|ACXP - Earnings growth in current year|Earnings growth forecast for next year Acurx Pharmaceuticals
- sales volume and revenue information:
ACXP - Company Revenue|Company Future Revenue Acurx|ACXP - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Acurx Pharmaceuticals
Fundamental valuation:Acurx Pharmaceuticals
Signature product of Acurx

Acurx Pharmaceuticals' development of selective antibiotics against superbugs requires colossal investments that impact net income. This metric is calculated as the ratio of current earnings per share to the same figure from the previous year, quantifying the capitalization efficiency of R&D processes. The trend in the percentage change of earnings per share compared to last year allows for the filtering of market noise, revealing the company's real fundamental progress.

Direct competitors

Net earnings per share growth this year Armata